Combination of lapatinib and trastuzumab shrinks HER2 positive breast cancer …

Combination of lapatinib and trastuzumab shrinks HER2 positive breast cancer …

Approximately a quarter of women with HER2 positive breast cancer, who were treated with a combination of the targeted drugs lapatinib and trastuzumab before surgery and chemotherapy, saw their tumours shrink significantly or even disappear, according …

(Visited 5 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.